Monsanto Co. (NYSE:MON) – Research analysts at Jefferies Group lifted their FY2019 earnings estimates for shares of Monsanto in a research note issued to investors on Thursday. Jefferies Group analyst L. Alexander now expects that the firm will post earnings per share of $6.40 for the year, up from their prior forecast of $6.25. Jefferies Group has a “Buy” rating on the stock.

A number of other research analysts also recently issued reports on MON. S&P Equity Research reiterated a “positive” rating on shares of Monsanto in a research note on Thursday, September 15th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Monsanto in a research note on Thursday, June 30th. Monness Crespi & Hardt decreased their price target on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research note on Monday, October 3rd. Zacks Investment Research downgraded shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Friday, July 1st. Finally, BMO Capital Markets reiterated an “outperform” rating and issued a $128.00 price target on shares of Monsanto in a research note on Saturday. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $114.65.

Earnings History and Estimates for Monsanto (NYSE:MON)

Monsanto (NYSE:MON) traded down 0.140% during midday trading on Monday, hitting $103.215. The stock had a trading volume of 179,546 shares. The stock has a 50-day moving average of $104.87 and a 200-day moving average of $101.43. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The firm has a market cap of $45.18 billion, a P/E ratio of 34.543 and a beta of 1.19.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period last year, the business earned ($0.19) EPS. The business’s quarterly revenue was up 8.8% on a year-over-year basis.

Large investors have recently added to or reduced their stakes in the company. WFG Advisors LP increased its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the last quarter. Signaturefd LLC increased its position in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC increased its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the last quarter. Pinkerton Retirement Specialists LLC increased its position in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the last quarter. Finally, Carnick & Kubik LLC purchased a new position in shares of Monsanto during the first quarter valued at $130,000. Institutional investors and hedge funds own 79.02% of the company’s stock.

In related news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction dated Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now directly owns 21,583 shares in the company, valued at approximately $2,196,501.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the sale, the chief operating officer now owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s dividend payout ratio is presently 71.05%.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.